Natco Pharma Plans ₹1,300 Cr Rights Issue

Natco Pharma Ltd's Board of Directors has approved a rights issue to raise up to ₹1,300 crore. The funds will be raised by issuing fully paid-up equity shares to eligible shareholders. A Fund-Raising Committee has been constituted to oversee the process. The company also provided an update on its Scheme of Arrangement (Demerger) with Natco Crop Health Sciences Limited, noting that the rights issue may necessitate changes to the scheme to maintain the proposed share swap ratio. The stock exchanges have issued observation letters for the demerger scheme, but filings with the National Company Law Tribunal are pending.